The dermatological products market is likely to grow at a steady pace in the long run, as per the latest report by Fact.MR. The demand for dermatological products continue to remain influenced with new formulations developed by manufacturers to treat various skin conditions and diseases.

Request to View Sample of Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2363

The demand for dermo-cosmetic products combining OTC and prescription products to treat acne, skin infections, atopic dermatitis and other skin conditions is also increasing. Fact.MR estimates that the sales of dermatological products is expected to surpass US$ 13,000 million by the end of 2018.

The demand for dermatological products is likely to be the highest among female consumers. Owing to the increasing skin diseases such as acne, rosacea, skin cancer, in women the maximum demand in dermatological products market is from female customers. The demand for dermo-cosmetic products is also rising among women. Also, over-the-counter anti-aging dermatological products are gaining popularity among female consumers.

Demand for Dermatological Products to Remain High in North America

North America is expected to witness significant growth in the demand and sales of dermatological products in 2018. Growing number of skin diseases across all age groups in the US is likely to create growth opportunities for manufacturers in the dermatological products market in the region.

According to the American Academy of Dermatology, acne is the most common skin condition in the US, affecting around 50 million people every year. Moreover, nearly 7.5 million people in the US suffer from psoriasis. Majority of dermatological products treating acne, psoriasis, and other skin conditions have been approved by Food and Drug Administration (FDA) in last few years, while many dermatological products are still under process of approval.   

Advent of Biologics Therapy to Revolutionize Dermatological Products Market

Biologic agents or protein-based drugs are increasingly used in dermatology for treatment of psoriasis. These products have also gained traction in the treatment of other inflammatory skin diseases. Treatment of psoriasis is the largest area of development for dermatological biologics. There are around 10 approved biologics in the dermatological products market to treat moderate to severe psoriasis.

With advancement in biomedical science, manufacturers in dermatological products market are using new technologies such as bioinformatics, biomarkers, nanotechnology, and molecular targeting for medicine discovery. Production of biosimilars is likely to increase in dermatological products market as these drugs have similar active ingredients to biologic medicines and are more cost-effective.

Based on the regulatory approach of biosimilars, increasing number of biosimilar drugs are set to enter Europe and the US in the coming years. Moreover, with increasing prevalence of psoriasis in children across the world, manufacturers in dermatological products market are working towards developing effective biologics for children with psoriasis.

Dermo-Cosmetic Products Emerging as an Effective Solution for Skin Related Complaints

The rise in skin allergies and lifestyle-related skin complaints is resulting in increasing use of dermo-cosmetic products by consumers to treat common skin conditions such as eczema, acne, extreme skin sensitivity, and reactive skin. Majority of the dermo-cosmetics products are developed on a large scale in Western European countries including Italy, France, and Spain.

New dermatological products formulas and developments are also on a rise, for instance, Pierre Fabre has launched sterile cosmetics, industries first sterile skincare line made without preservatives and fragrance. The company used a limited number of ingredients and offers D.E.F.I. (Device for Exclusive Formula Integrity) packaging. The packaging helps to protect formula from oxidation.

In order to gain customer interest, brands in the dermatological products market are working with dermatologists to develop the formulation and also attach dermatologist-recommended claim. Dermatologists recommended brands are witnessing a rise in demand due to consumer belief that these dermatological products are safe and effective.

A Customization of this Report is Available upon Request @ https://www.factmr.com/connectus/sample?flag=RM&rep_id=2363

Increasing Prevalence of Skin Problems among Children Driving Dermatological Products Demand

Skin diseases constitute a major health problem among children worldwide. Most common skin conditions found in children are skin rashes, diaper dermatitis, atopic dermatitis, acne, and warts. According to the American Academy of Dermatology, nearly 25% of children compared to 2-3% of adults are affected by atopic dermatitis. Hence, manufacturers in dermatological products market are developing over-the-counter medications, as most of the skin problems in children are treatable with these medications.

Eczema is also emerging as a common skin problem among children due to the rise in viruses, bacteria, and fungi. Moisturizers treating eczema are being developed on a large scale. Moreover, diaper rash is the most common problem among babies. This is driving the demand for dermatological products including medicated creams and moisturizers especially developed to treat diaper rash.